Sempresto Featured After Alerje Autoinjector Platform Buy
19 Mar 2026 //
BUSSINESSWIRE
Sempresto Acquires Alerje`s Autoinjector Platform
04 Dec 2025 //
BUSINESSWIRE
Alerje Earns $1M Phase II NSF Award to Support Food Allergy Immunotherapy
07 Sep 2023 //
BUSINESSWIRE

Market Place
Sourcing Support